| 1 |
Li X, Jiang X, Zhou X, Cheng Y, Cao F. Development of dexamethasone suspension eye drops: A comparative investigation of ternary and quaternary cyclodextrin aggregates. Journal of Drug Delivery Science and Technology 2023;82:104383. [DOI: 10.1016/j.jddst.2023.104383] [Reference Citation Analysis]
|
| 2 |
Manasa R, Shivananjappa M. Role of Nanotechnology‐Based Materials in Drug Delivery. Advances in Novel Formulations for Drug Delivery 2023. [DOI: 10.1002/9781394167708.ch15] [Reference Citation Analysis]
|
| 3 |
Yasri S, Wiwanitkit V. Emerging Trends of Ocular Drug Delivery. Advances in Novel Formulations for Drug Delivery 2023. [DOI: 10.1002/9781394167708.ch18] [Reference Citation Analysis]
|
| 4 |
Wu KY, Ashkar S, Jain S, Marchand M, Tran SD. Breaking Barriers in Eye Treatment: Polymeric Nano-Based Drug-Delivery System for Anterior Segment Diseases and Glaucoma. Polymers 2023;15:1373. [DOI: 10.3390/polym15061373] [Reference Citation Analysis]
|
| 5 |
Pardeshi SR, More MP, Kulkarni AD, Pardeshi CV, Patil PB, Patil AS, Giram PS, Mahajan HS, Deshmukh PK, Ige PP, Patil GK, Naik JB. Current perspectives in nanomedicine delivery for targeted ocular therapeutics. Bull Mater Sci 2023;46:35. [DOI: 10.1007/s12034-022-02869-0] [Reference Citation Analysis]
|
| 6 |
Zashikhina N, Gladnev S, Sharoyko V, Korzhikov-Vlakh V, Korzhikova-Vlakh E, Tennikova T. Synthesis and Characterization of Nanoparticle-Based Dexamethasone-Polypeptide Conjugates as Potential Intravitreal Delivery Systems. Int J Mol Sci 2023;24. [PMID: 36835114 DOI: 10.3390/ijms24043702] [Reference Citation Analysis]
|
| 7 |
Mohan P, Rajeswari J, Kesavan K. TPGS-Chitosan Conjugated Mucoadhesive Micelles of Brinzolamide for Glaucoma Therapy: in vitro and in vivo Evaluation. Materialia 2023. [DOI: 10.1016/j.mtla.2023.101711] [Reference Citation Analysis]
|
| 8 |
Gogoi NR, Marbaniang D, Pal P, Ray S, Mazumder B. Targeted Nanotherapies for the Posterior Segment of the Eye: An Integrative Review on Recent Advancements and Challenges. Pharm Nanotechnol 2022;10:268-78. [PMID: 35946098 DOI: 10.2174/2211738510666220806102612] [Reference Citation Analysis]
|
| 9 |
Dludla SBK, Mashabela LT, Ng’andwe B, Makoni PA, Witika BA. Current Advances in Nano-Based and Polymeric Stimuli-Responsive Drug Delivery Targeting the Ocular Microenvironment: A Review and Envisaged Future Perspectives. Polymers 2022;14:3580. [DOI: 10.3390/polym14173580] [Reference Citation Analysis]
|
| 10 |
H. El-kamel A, A. Ashour A. Recent Strategies for Ocular Drug Delivery: Promises and Challenges. Advances in Drug Delivery Methods [Working Title] 2022. [DOI: 10.5772/intechopen.106335] [Reference Citation Analysis]
|
| 11 |
Cai Y, Qi J, Lu Y, He H, Wu W. The in vivo fate of polymeric micelles. Adv Drug Deliv Rev 2022;:114463. [PMID: 35905947 DOI: 10.1016/j.addr.2022.114463] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 12 |
Liu H, Liu D, Ji M, Xiao P, Qin Y, Zhao J, Wang N, Gou J, Yin T, He H, Chen G, Zhang Y, Tang X. Inflammation-targeted sialic acid-dexamethasone conjugates for reducing the side effects of glucocorticoids. Int J Pharm 2022;622:121900. [PMID: 35690305 DOI: 10.1016/j.ijpharm.2022.121900] [Reference Citation Analysis]
|
| 13 |
Wu H, Xu Y, Cai M, You L, Liu J, Dong X, Yin X, Ni J, Qu C. Design of an L-Valine-Modified Nanomicelle-Based Drug Delivery System for Overcoming Ocular Surface Barriers. Pharmaceutics 2022;14:1277. [PMID: 35745853 DOI: 10.3390/pharmaceutics14061277] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 14 |
Madamsetty VS, Mohammadinejad R, Uzieliene I, Nabavi N, Dehshahri A, García-Couce J, Tavakol S, Moghassemi S, Dadashzadeh A, Makvandi P, Pardakhty A, Aghaei Afshar A, Seyfoddin A. Dexamethasone: Insights into Pharmacological Aspects, Therapeutic Mechanisms, and Delivery Systems. ACS Biomater Sci Eng 2022;8:1763-90. [PMID: 35439408 DOI: 10.1021/acsbiomaterials.2c00026] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 15 |
Chaudhari P, Shetty D, Lewis SA. Recent progress in colloidal nanocarriers loaded in situ gel in ocular therapeutics. Journal of Drug Delivery Science and Technology 2022;71:103327. [DOI: 10.1016/j.jddst.2022.103327] [Reference Citation Analysis]
|
| 16 |
Javed S, Mangla B, Almoshari Y, Sultan MH, Ahsan W. Nanostructured lipid carrier system: A compendium of their formulation development approaches, optimization strategies by quality by design, and recent applications in drug delivery. Nanotechnology Reviews 2021;11:1744-77. [DOI: 10.1515/ntrev-2022-0109] [Reference Citation Analysis]
|
| 17 |
Sun L, Zhang M, Shi Y, Fang L, Cao F. Rational design of mixed nanomicelle eye drops with structural integrity investigation. Acta Biomater 2022;141:164-77. [PMID: 35032720 DOI: 10.1016/j.actbio.2022.01.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 18 |
Peng C, Kuang L, Zhao J, Ross AE, Wang Z, Ciolino JB. Bibliometric and visualized analysis of ocular drug delivery from 2001 to 2020. Journal of Controlled Release 2022. [DOI: 10.1016/j.jconrel.2022.03.031] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 19 |
Sorasitthiyanukarn FN, Muangnoi C, Rojsitthisak P, Rojsitthisak P. Chitosan oligosaccharide/alginate nanoparticles as an effective carrier for astaxanthin with improving stability, in vitro oral bioaccessibility, and bioavailability. Food Hydrocolloids 2022;124:107246. [DOI: 10.1016/j.foodhyd.2021.107246] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 22.0] [Reference Citation Analysis]
|
| 20 |
Zhao F, Fan S, Ghate D, Romanova S, Bronich TK, Zhao S. A Hydrogel Ionic Circuit Based High-Intensity Iontophoresis Device for Intraocular Macromolecule and Nanoparticle Delivery. Adv Mater 2022;34:e2107315. [PMID: 34716729 DOI: 10.1002/adma.202107315] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 21 |
Allyn MM, Luo RH, Hellwarth EB, Swindle-reilly KE. Considerations for Polymers Used in Ocular Drug Delivery. Front Med 2022;8:787644. [DOI: 10.3389/fmed.2021.787644] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 22 |
Akhter MH, Ahmad I, Alshahrani MY, Al-harbi AI, Khalilullah H, Afzal O, Altamimi ASA, Najib Ullah SNM, Ojha A, Karim S. Drug Delivery Challenges and Current Progress in Nanocarrier-Based Ocular Therapeutic System. Gels 2022;8:82. [DOI: 10.3390/gels8020082] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
|
| 23 |
Wang L, Cheng R, Sun X, Zhao Y, Yang Y, Gao Y, Ding Z, Ge W, Liu J, Wang S, Zhang J. Safety assessment of functional oligooctasaccharide riclinoctaose: A pilot study of genotoxicity, acute toxicity, and subchronic toxicity. Journal of Food Science. [DOI: 10.1111/1750-3841.16039] [Reference Citation Analysis]
|
| 24 |
Li Y, Zhou L, Zhang M, Li R, Di G, Liu H, Wu X. Micelles based on polyvinylpyrrolidone VA64: A potential nanoplatform for the ocular delivery of apocynin. Int J Pharm 2022;:121451. [PMID: 35051535 DOI: 10.1016/j.ijpharm.2022.121451] [Reference Citation Analysis]
|
| 25 |
Sun X, Sheng Y, Li K, Sai S, Feng J, Li Y, Zhang J, Han J, Tian B. Mucoadhesive phenylboronic acid conjugated chitosan oligosaccharide-vitamin E copolymer for topical ocular delivery of voriconazole: Synthesis, in vitro/vivo evaluation, and mechanism. Acta Biomater 2022;138:193-207. [PMID: 34757228 DOI: 10.1016/j.actbio.2021.10.047] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 26 |
Niculescu AG, Grumezescu AM. Applications of Chitosan-Alginate-Based Nanoparticles-An Up-to-Date Review. Nanomaterials (Basel) 2022;12:186. [PMID: 35055206 DOI: 10.3390/nano12020186] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 28.0] [Reference Citation Analysis]
|
| 27 |
Löscher M, Seiz C, Hurst J, Schnichels S. Topical Drug Delivery to the Posterior Segment of the Eye. Pharmaceutics 2022;14:134. [PMID: 35057030 DOI: 10.3390/pharmaceutics14010134] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 28 |
García-silva I, Palestino G, Gonzalez-ortega O. The potential of drug delivery nanosystems to treat COVID-19. Biomedical Innovations to Combat COVID-19 2022. [DOI: 10.1016/b978-0-323-90248-9.00018-8] [Reference Citation Analysis]
|
| 29 |
Choudhury H, Gorain B, Pandey M, Nirmal J, Kesharwani P. Surface engineering of nanoparticles for imparting multifunctionality. Nanoparticle Therapeutics 2022. [DOI: 10.1016/b978-0-12-820757-4.00001-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 30 |
Tasharrofi N, Nourozi M, Marzban A. How liposomes pave the way for ocular drug delivery after topical administration. Journal of Drug Delivery Science and Technology 2022;67:103045. [DOI: 10.1016/j.jddst.2021.103045] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 31 |
Solanki A, Thakore S. Self-assembled nanomaterials for drug delivery. Design, Principle and Application of Self-Assembled Nanobiomaterials in Biology and Medicine 2022. [DOI: 10.1016/b978-0-323-90984-6.00013-1] [Reference Citation Analysis]
|
| 32 |
Singh TV, Shagolsem LS. Recent Advances in Nanostructured Polymers. Materials Horizons: From Nature to Nanomaterials 2022. [DOI: 10.1007/978-981-16-8391-6_12] [Reference Citation Analysis]
|
| 33 |
Antimisiaris SG, Natsaridis E. Nanovesicles for ocular drug delivery. Applications of Nanovesicular Drug Delivery 2022. [DOI: 10.1016/b978-0-323-91865-7.00025-0] [Reference Citation Analysis]
|
| 34 |
Li Q, Xin M, Wu X, Lei B. A nano-phytochemical ophthalmic solution for marked improvement of corneal wound healing in healthy or diabetic mice. Nanomedicine (Lond) 2021. [PMID: 34927467 DOI: 10.2217/nnm-2021-0417] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 35 |
Li Q, Wu X, Xin M. Strengthened rebamipide ocular nanoformulation to effectively treat corneal alkali burns in mice through the HMGB1 signaling pathway. Exp Eye Res 2021;213:108824. [PMID: 34742693 DOI: 10.1016/j.exer.2021.108824] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 36 |
Mukhtar M, Fényes E, Bartos C, Zeeshan M, Ambrus R. Chitosan biopolymer, its derivatives and potential applications in nano-therapeutics: A comprehensive review. European Polymer Journal 2021;160:110767. [DOI: 10.1016/j.eurpolymj.2021.110767] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 37 |
Mijanović O, Pylaev T, Nikitkina A, Artyukhova M, Branković A, Peshkova M, Bikmulina P, Turk B, Bolevich S, Avetisov S, Timashev P. Tissue Engineering Meets Nanotechnology: Molecular Mechanism Modulations in Cornea Regeneration. Micromachines (Basel) 2021;12:1336. [PMID: 34832752 DOI: 10.3390/mi12111336] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 38 |
Burhan AM, Klahan B, Cummins W, Andrés-Guerrero V, Byrne ME, O'Reilly NJ, Chauhan A, Fitzhenry L, Hughes H. Posterior Segment Ophthalmic Drug Delivery: Role of Muco-Adhesion with a Special Focus on Chitosan. Pharmaceutics 2021;13:1685. [PMID: 34683978 DOI: 10.3390/pharmaceutics13101685] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 39 |
Di Prima G, Licciardi M, Bongiovì F, Pitarresi G, Giammona G. Inulin-Based Polymeric Micelles Functionalized with Ocular Permeation Enhancers: Improvement of Dexamethasone Permeation/Penetration through Bovine Corneas. Pharmaceutics 2021;13:1431. [PMID: 34575507 DOI: 10.3390/pharmaceutics13091431] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 40 |
Narayana S, Ahmed MG, Gowda BHJ, Shetty PK, Nasrine A, Thriveni M, Noushida N, Sanjana A. Recent advances in ocular drug delivery systems and targeting VEGF receptors for management of ocular angiogenesis: A comprehensive review. Futur J Pharm Sci 2021;7. [DOI: 10.1186/s43094-021-00331-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 41 |
Güven UM, Başaran E. In vitro-in vivo evaluation of olopatadine incorporated chitosan nanoparticles for the treatment of ocular allergy. Journal of Drug Delivery Science and Technology 2021;64:102518. [DOI: 10.1016/j.jddst.2021.102518] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 42 |
Koutsoviti M, Siamidi A, Pavlou P, Vlachou M. Recent Advances in the Excipients Used for Modified Ocular Drug Delivery. Materials (Basel) 2021;14:4290. [PMID: 34361483 DOI: 10.3390/ma14154290] [Reference Citation Analysis]
|
| 43 |
Mofidfar M, Abdi B, Ahadian S, Mostafavi E, Desai TA, Abbasi F, Sun Y, Manche EE, Ta CN, Flowers CW. Drug delivery to the anterior segment of the eye: A review of current and future treatment strategies. Int J Pharm 2021;607:120924. [PMID: 34324989 DOI: 10.1016/j.ijpharm.2021.120924] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 44 |
Silva B, São Braz B, Delgado E, Gonçalves L. Colloidal nanosystems with mucoadhesive properties designed for ocular topical delivery. Int J Pharm 2021;606:120873. [PMID: 34246741 DOI: 10.1016/j.ijpharm.2021.120873] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 45 |
Xu C, Lu J, Zhou L, Liang J, Fang L, Cao F. Multifunctional nanocomposite eye drops of cyclodextrin complex@layered double hydroxides for relay drug delivery to the posterior segment of the eye. Carbohydr Polym 2021;260:117800. [PMID: 33712148 DOI: 10.1016/j.carbpol.2021.117800] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 46 |
Navarro-Partida J, Castro-Castaneda CR, Santa Cruz-Pavlovich FJ, Aceves-Franco LA, Guy TO, Santos A. Lipid-Based Nanocarriers as Topical Drug Delivery Systems for Intraocular Diseases. Pharmaceutics 2021;13:678. [PMID: 34065059 DOI: 10.3390/pharmaceutics13050678] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 47 |
Dubashynskaya NV, Bokatyi AN, Skorik YA. Dexamethasone Conjugates: Synthetic Approaches and Medical Prospects. Biomedicines 2021;9:341. [PMID: 33801776 DOI: 10.3390/biomedicines9040341] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 48 |
Hami Z. A Brief Review on Advantages of Nano-based Drug Delivery Systems. Ann Mil Health Sci Res 2021;19. [DOI: 10.5812/amh.112274] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 49 |
Silva NSD, Araújo NK, Daniele-Silva A, Oliveira JWF, Medeiros JM, Araújo RM, Ferreira LS, Rocha HAO, Silva-Junior AA, Silva MS, Fernandes-Pedrosa MF. Antimicrobial Activity of Chitosan Oligosaccharides with Special Attention to Antiparasitic Potential. Mar Drugs 2021;19:110. [PMID: 33673266 DOI: 10.3390/md19020110] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 50 |
Kumara BN, Shambhu R, Prasad KS. Why chitosan could be apt candidate for glaucoma drug delivery - An overview. Int J Biol Macromol 2021;176:47-65. [PMID: 33581206 DOI: 10.1016/j.ijbiomac.2021.02.057] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
|
| 51 |
Sripetch S, Loftsson T. Topical drug delivery to the posterior segment of the eye: Thermodynamic considerations. Int J Pharm 2021;597:120332. [PMID: 33540025 DOI: 10.1016/j.ijpharm.2021.120332] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 52 |
Wang R, Gao Y, Liu A, Zhai G. A review of nanocarrier-mediated drug delivery systems for posterior segment eye disease: challenges analysis and recent advances. J Drug Target 2021;29:687-702. [PMID: 33474998 DOI: 10.1080/1061186X.2021.1878366] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 53 |
Natesan S, Vellayutham R, Krishnaswami V, Ponnusamy C, Thekkilaveedu S, Pathayappurakkal Mohanan D, Kandasamy R. Enhanced Topical Delivery of Drugs to the Eye Using Chitosan Based Systems. Advances in Polymer Science 2021. [DOI: 10.1007/12_2021_105] [Reference Citation Analysis]
|
| 54 |
Li Z, Liu M, Ke L, Wang L, Wu C, Li C, Li Z, Wu Y. Flexible polymeric nanosized micelles for ophthalmic drug delivery: research progress in the last three years. Nanoscale Adv 2021;3:5240-54. [DOI: 10.1039/d1na00596k] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 55 |
Layek B, Das S. Chitosan-based nanomaterials in drug delivery applications. Biopolymer-Based Nanomaterials in Drug Delivery and Biomedical Applications 2021. [DOI: 10.1016/b978-0-12-820874-8.00001-4] [Reference Citation Analysis]
|
| 56 |
Pramanik S, Sali V. Connecting the dots in drug delivery: A tour d'horizon of chitosan-based nanocarriers system. Int J Biol Macromol 2021;169:103-21. [PMID: 33338522 DOI: 10.1016/j.ijbiomac.2020.12.083] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 57 |
Kou L, Yao Q, Zhang H, Chu M, Bhutia YD, Chen R, Ganapathy V. Transporter-Targeted Nano-Sized Vehicles for Enhanced and Site-Specific Drug Delivery. Cancers (Basel) 2020;12:E2837. [PMID: 33019627 DOI: 10.3390/cancers12102837] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 58 |
Shahab MS, Rizwanullah M, Alshehri S, Imam SS. Optimization to development of chitosan decorated polycaprolactone nanoparticles for improved ocular delivery of dorzolamide: In vitro, ex vivo and toxicity assessments. Int J Biol Macromol 2020;163:2392-404. [PMID: 32979440 DOI: 10.1016/j.ijbiomac.2020.09.185] [Cited by in Crossref: 41] [Cited by in F6Publishing: 32] [Article Influence: 13.7] [Reference Citation Analysis]
|
| 59 |
Gote V, Ansong M, Pal D. Prodrugs and nanomicelles to overcome ocular barriers for drug penetration. Expert Opin Drug Metab Toxicol 2020;16:885-906. [PMID: 32729364 DOI: 10.1080/17425255.2020.1803278] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 5.7] [Reference Citation Analysis]
|
| 60 |
Begines B, Ortiz T, Pérez-Aranda M, Martínez G, Merinero M, Argüelles-Arias F, Alcudia A. Polymeric Nanoparticles for Drug Delivery: Recent Developments and Future Prospects. Nanomaterials (Basel) 2020;10:E1403. [PMID: 32707641 DOI: 10.3390/nano10071403] [Cited by in Crossref: 152] [Cited by in F6Publishing: 165] [Article Influence: 50.7] [Reference Citation Analysis]
|
| 61 |
Zamboulis A, Nanaki S, Michailidou G, Koumentakou I, Lazaridou M, Ainali NM, Xanthopoulou E, Bikiaris DN. Chitosan and its Derivatives for Ocular Delivery Formulations: Recent Advances and Developments. Polymers (Basel) 2020;12:E1519. [PMID: 32650536 DOI: 10.3390/polym12071519] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 14.0] [Reference Citation Analysis]
|
| 62 |
Karava A, Lazaridou M, Nanaki S, Michailidou G, Christodoulou E, Kostoglou M, Iatrou H, Bikiaris DN. Chitosan Derivatives with Mucoadhesive and Antimicrobial Properties for Simultaneous Nanoencapsulation and Extended Ocular Release Formulations of Dexamethasone and Chloramphenicol Drugs. Pharmaceutics 2020;12:E594. [PMID: 32604758 DOI: 10.3390/pharmaceutics12060594] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 63 |
Han H, Yin Q, Tang X, Yu X, Gao Q, Tang Y, Grzybowski A, Yao K, Ji J, Shentu X. Development of mucoadhesive cationic polypeptide micelles for sustained cabozantinib release and inhibition of corneal neovascularization. J Mater Chem B 2020;8:5143-54. [PMID: 32420566 DOI: 10.1039/d0tb00874e] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 5.7] [Reference Citation Analysis]
|
| 64 |
Meza-Rios A, Navarro-Partida J, Armendariz-Borunda J, Santos A. Therapies Based on Nanoparticles for Eye Drug Delivery. Ophthalmol Ther 2020;9:1-14. [PMID: 32383107 DOI: 10.1007/s40123-020-00257-7] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
|
| 65 |
Tsanaktsidou E, Karavasili C, Zacharis CK, Fatouros DG, Markopoulou CK. Partial Least Square Model (PLS) as a Tool to Predict the Diffusion of Steroids Across Artificial Membranes. Molecules 2020;25:E1387. [PMID: 32197506 DOI: 10.3390/molecules25061387] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 66 |
Terreni E, Chetoni P, Tampucci S, Burgalassi S, Al-Kinani AA, Alany RG, Monti D. Assembling Surfactants-Mucoadhesive Polymer Nanomicelles (ASMP-Nano) for Ocular Delivery of Cyclosporine-A. Pharmaceutics 2020;12:E253. [PMID: 32168973 DOI: 10.3390/pharmaceutics12030253] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 67 |
Nayak K, Misra M. PEGylated microemulsion for dexamethasone delivery to posterior segment of eye. J Biomater Sci Polym Ed 2020;31:1071-90. [PMID: 32149562 DOI: 10.1080/09205063.2020.1740964] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
